Li Xing

CEO

LexBio Therapeutics

Short Biography

Dr. Xing has nearly thirty years’ industrial experience in pharmaceutical research. Previously at WuXi AppTec in Boston, she built the AI drug discovery function from ground up. Prior to joining WuXi she was a principal investigator at Pfizer for more than fifteen years, where she co-invented multiple clinical candidates and supervised postdoctoral researchers. Dr. Xing has published more than a hundred peer-reviewed journal articles and international patents, including thirty US granted patents. She received her Ph.D. in polymer science from University of Akron, and double bachelor’s degrees in solid state physics and computer technology from Tsinghua University.

Panel Discussion: Molecular Glues and Targeted Protein Degradation: Opportunities, Challenges, and Collaboration